QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
Researchers identify associations between B12 levels currently accepted as normal and markers of neurological injury or ...